We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRSO icon
2426
Peraso
PRSO
$10.8M
$118K ﹤0.01%
5
+1
+25% +$28.3K
UCTT
2427
Ultra Clean Holdings
UCTT
$3.9B
$115K ﹤0.01%
+12,700
New +$121K
SOHO
2428
DELISTED
Sotherly Hotels
SOHO
$114K ﹤0.01%
14,600
+300
+2% +$2.15K
CVO
2429
DELISTED
Cenevo, Inc.
CVO
$113K ﹤0.01%
3,813
HCKT icon
2430
Hackett Group
HCKT
$285M
$109K ﹤0.01%
18,220
NGD
2431
DELISTED
New Gold Inc
NGD
$109K ﹤0.01%
+17,200
New +$92.7K
LF
2432
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$109K ﹤0.01%
+14,800
New +$104K
PSTB
2433
DELISTED
Park Sterling Corp.
PSTB
$108K ﹤0.01%
16,377
SRI icon
2434
Stoneridge
SRI
$193M
$107K ﹤0.01%
+10,000
New +$105K
MSO
2435
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
$106K ﹤0.01%
22,519
BSTG
2436
DELISTED
Biostage, Inc. Common Stock
BSTG
$105K ﹤0.01%
+10,050
New +$85.6K
CWST icon
2437
Casella Waste Systems
CWST
$5.89B
$104K ﹤0.01%
20,775
WMAR
2438
DELISTED
West Marine Inc
WMAR
$104K ﹤0.01%
10,100
GNE icon
2439
Genie Energy
GNE
$384M
$100K ﹤0.01%
12,742
PCYO icon
2440
Pure Cycle
PCYO
$275M
$100K ﹤0.01%
14,700
BSF
2441
DELISTED
Bear State Financial, Inc.
BSF
$100K ﹤0.01%
12,511
VOXX
2442
DELISTED
VOXX International Corporation Class A
VOXX
$98K ﹤0.01%
10,364
ACW
2443
DELISTED
Accuride Corp
ACW
$95K ﹤0.01%
19,500
+9,500
+95% +$48.5K
EVBS
2444
DELISTED
Eastern Virginia Bankshares In
EVBS
$95K ﹤0.01%
14,876
+100
+0.7% +$663
NL icon
2445
NLI Holdings
NL
$313M
$93K ﹤0.01%
10,000
FBP icon
2446
First Bancorp
FBP
$4.43B
$92K ﹤0.01%
17,000
PW
2447
Power REIT
PW
$2.94M
$92K ﹤0.01%
1,013
+10
+1% +$919
AXAS
2448
DELISTED
Abraxas Petroleum Corp
AXAS
$91K ﹤0.01%
730
III icon
2449
Information Services Group
III
$250M
$89K ﹤0.01%
18,600
IDXG
2450
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$89K ﹤0.01%
204
+5
+3% +$2.31K

Similar funds

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.